- Heath software company Comodo Health looked at claims data for anti-parasite drug ivermectin
- Monthly average up 72% from 39,864 in 2019 to 68,428 in 2021
- Idaho saw the biggest increase from 116 prescriptions per month in 2019 to 417 per month in 2021 – a 258% spike
- Several specialties that do not usually treat conditions for which medicine saw a boom in prescriptions, including anesthesiology and cardiology
- The misinformation about ivermectin is based on a false 2020 study that found that high concentrations of the drug may prevent the virus from replicating.
- A version of the drug is safe for use in humans and approved by the FDA, but has not been shown to treat viruses such as COVID-19.
The number of monthly ivermectin prescriptions skyrocketed in 2021 as many people abused the anti-parasitic drug to combat COVID-19.
Ivermectin is safe for human use in small doses, and is approved by the Food and Drug Administration (FDA) for the treatment of parasitic infections.
However, in recent months it has become the center of attention due to social media rumours, leading many to believe that the drug can treat or prevent COVID-19.
Doctors say that it has no potential to treat Kovid, nor is the drug approved by the FDA to treat the virus.
An analysis by health software company Comodo Health found that monthly prescriptions increased by 72 percent in 2019 to 68,428 in 2019.
Heath software company Comodo Health looked at claims data for anti-parasite drug ivermectin and found that the monthly average rose 72% from 39,864 in 2019 to 68,428 in 2021 (above).
The misinformation about ivermectin is based on a false 2020 study that found that high concentrations of the drug could stop the virus from replicating (file image)
For report good, published on Tuesday, Comodo Health looked at claims data collected by the company from January 2019 to May 2119.
The team found that the number of prescriptions for ivermectin increased from a monthly average of 39,864 to 40,347 in 2020, to 68,428 in 2021, a 72 percent increase.
Over a 29-month time period, the highest monthly average was seen in January 2021 at 97,192.
Various changes by state — a 258 percent spike, with the largest overall increase in Idaho from 116 prescriptions per month in 2019 to 417 per month in 2021.
The top five were New Mexico (216 percent), Wyoming (204 percent), Mississippi (198 percent) and South Dakota (196 percent).
The report also found The average number of healthcare providers dispensing medication per month grew by 34 percent from 2019 to 2021.
New Mexico saw the biggest jump of 172 percent, followed by South Dakota (118 percent), Alaska (117 percent), Idaho (109 percent) and Wyoming (108 percent).
Additionally, the report found that the largest increases in ivermectin prescriptions were seen in specialties that do not typically treat conditions — such as parasitic infestations, scabies or head lice — for which the drug is used. .
Anesthesiologists saw the biggest increase in prescriptions at 1,319 percent between 2019 and 2021.
It was followed by physical medicine and rehabilitation (1,301 percent), pulmonary disease (1,167 percent), alternative care (879 percent) and cardiology (741 percent).
Idaho saw the biggest increase from 116 prescriptions per month in 2019 to 417 per month in 2021 – a 258% spike
New Mexico saw the biggest jump in the average number of healthcare providers prescribing medication per month at 172%.
‘Since no change has been observed in the prevalence of any condition for which ivermectin is approved to treat, there has been a huge increase in both prescriptions for ivermectin and healthcare providers for COVID-19, despite warnings from health officials. Related to off-label use for -19. Its efficacy is lacking,’ the authors report.
‘This indicates a related trend of departure from evidence-based care. This is happening side-by-side with hesitation from patients to get FDA-approved vaccines.
‘It is the responsibility of certified clinical professionals to adhere to guidelines in the treatment of their patients, as well as combat misinformation and serve as models in encouraging trust and adherence to guidelines.
‘Providers writing prescriptions against CDC, FDA and other health agencies’ guidelines during a public health crisis may indicate a systemic issue requiring further research. ‘
Misinformation about the drug’s ability to fight viruses such as SARS-CoV-2, which causes Covid, surfaced last year after an Australian study found that the drug could hinder the replication of virus cells. Is.
Many said the findings proved ivermectin was an effective COVID treatment – and could even replace vaccine use.
Several specialties that do not usually treat conditions for which medicine saw a boom in prescriptions, including anesthesiology and cardiology
However, Dr Timothy Geary, one of the world’s top parasitologists, explained to DailyMail.com in an interview last month that the study’s findings cannot be translated to humans because the doses used are too high to be considered safe. Was.
‘In that study they showed that, in cell cultures, ivermectin could inhibit’ [Covid] replication, but the concentrations needed to have that effect were in a range called the micromolar range – very high concentrations relative to what you would find in the plasma of a treated person or animal, which would be 20 to 50 times lower,’ he said. .
‘At high concentrations in cell culture, many compounds can have all kinds of effects, but when you look at what we call pharmacological levels – what we actually see and treat patients – it’s much more than that. Is [what would be used in humans]
‘So the standard doses of ivermectin that we use for people are never going to reach the level that would be effective against the virus based on that one study.’
However, Geary said ivermectin is safe for humans in small doses, with some…